Found 367 matching trials
A Real World Study of Regogfinib in HCC N/A This is a non-interventional observational study with the primary objective...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma PHASE3 The objective of this study was to evaluate efficacy and safety of regorafe...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors. PHASE1 This study is to define the pharmacokinetics and to evaluate the safety of ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME) PHASE2 To measure the level of circulating tumor DNA (ctDNA) in the blood of color...
Show More Location
Multiple Locations
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer PHASE3 The goal of this clinical trial is to demonstrate the non-inferiority of tr...
Show More Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma PHASE2 The purpose of this study is to determine the safety and tolerability of Re...
Show More Location
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Learn More & Join Trial
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer N/A Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC NA The aim of this clinical trial is to find out whether Regorafenib and Sinti...
Show More Location
The First People's Hospital of Changzhou
Learn More & Join Trial